Scan to download
BTC $61,345.58 -1.89%
ETH $1,587.41 -4.76%
BNB $581.23 -0.99%
XRP $1.10 -1.96%
SOL $63.26 -3.25%
TRX $0.3197 -1.59%
DOGE $0.0820 -1.90%
ADA $0.1589 -0.28%
BCH $225.10 +0.79%
LINK $7.43 -1.33%
HYPE $60.32 -1.88%
AAVE $62.10 -8.49%
SUI $0.7102 +1.73%
XLM $0.2024 +7.05%
ZEC $375.42 +19.87%
BTC $61,345.58 -1.89%
ETH $1,587.41 -4.76%
BNB $581.23 -0.99%
XRP $1.10 -1.96%
SOL $63.26 -3.25%
TRX $0.3197 -1.59%
DOGE $0.0820 -1.90%
ADA $0.1589 -0.28%
BCH $225.10 +0.79%
LINK $7.43 -1.33%
HYPE $60.32 -1.88%
AAVE $62.10 -8.49%
SUI $0.7102 +1.73%
XLM $0.2024 +7.05%
ZEC $375.42 +19.87%

The listed company Galmed plans to allocate 50% of its cash reserves to cryptocurrency

2025-08-25 20:00:41
Collection

ChainCatcher news, according to PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, with plans to allocate $10 million (approximately 50% of current cash reserves) for digital asset investments.

The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies.

To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.

app_icon
ChainCatcher Building the Web3 world with innovations.